To include your compound in the COVID-19 Resource Center, submit it here.

Bristol-Myers, Merck, Ono Pharmaceutical cancer news

Bristol-Myers and Ono filed suit in the U.S. District Court for the District of Delaware against Merck alleging that Merck's Keytruda pembrolizumab infringes U.S. Patent No. 8,728,474 covering

Read the full 288 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE